Table 1.
Study period |
||||||||
---|---|---|---|---|---|---|---|---|
Enrolment | Allocation | Postallocation Antibiotic therapy |
Close-out (after the end of follow-up period) | |||||
Time point | Day 1 | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Every day | |
Enrolment | ||||||||
Eligibility screen | X | |||||||
Informed consent | X | |||||||
Randomisation of the participant | X | |||||||
Study product distribution | X | |||||||
Diary of symptoms | X | |||||||
Interventions | ||||||||
Lactobacillus reuteri DSM 17938 | ||||||||
Placebo | ||||||||
Assessments | ||||||||
Adverse events | X | X | X | X | X | X | ||
Stool analysis in case of diarrhoea/AAD | X | X | X | X | X | X | ||
Daily diary reporting | X | X | X | X | X | X | ||
Telephone contact to check diary reporting and compliance in outpatients | X | X | X | X | X | X | ||
Return of non-used study products | X |
AAD, antibiotic-associated diarrhoea.